期刊文献+

血浆NT-proBNP检测在COPD合并呼吸衰竭患者中的临床意义 被引量:5

Clinical Significance of Plasma NT-proBNP Detection in COPD Patients with Respiratory Failure
下载PDF
导出
摘要 目的:通过对COPD合并呼吸衰竭患者中血浆NT-proBNP水平进行检测,探讨其在COPD病情发展过程中的变化以及临床意义。方法:两组患者均于住院次日空腹抽取肘正中静脉血3 mL,以备检测血浆NT-proBNP水平,同时行动脉采血血气分析检测。采用加拿大瑞邦生物医学有限公司生产的锐普荧光干式定量分析仪严格按照说明操作进行检测血浆NT-proBNP。采用RocheOmnic血气分析仪测定动脉血氧分压(PaO2)、血二氧化碳分压(PaCO2)。结果:两组血清NT-proBNP水平比较差异有统计学意义(P<0.05),实验组明显高于正常对照组。不同程度低氧血症的NT-proBNP水平比较差异有统计学意义(P<0.05),提示:NT-proBNPs水平随着PaO2的降低而升高。实验组68例COPD患者PaO2与血清NT-proBNP水平呈负相关(一0.641,P<0.05),而PaC02与血清NT-proBNP水平无相关性(r=0.143,P>0.05)。结论:血浆NT-proBNP水平检测在COPD呼吸衰竭的诊断、病情严重程度以及发展变化的预测中均具有较好的临床价值,对指导治疗COPD呼吸衰竭患者有重要的意义,值得进一步研究。 Objective:To discuss the change and clinical significance of plasma NT-proBNP detection in the COPD patients developing process,through the plasma NT-proBNP detection for COPD patients with respiratory failure.Methods:All patients in the hospital the next day were extrated cubital vein 3mL,to prepare plasma NT-proBNP level and arterial blood gas analysis testing.Biomedical Co.,the Canadian Ruibang sharp production of dry general quantitative fluorescence analyzer in strict accordance with the instructions for plasma NT-proBNP.Blood gas analyzer were used to test RocheOmnic arterial oxygen pressure(PaO2),blood carbon dioxide partial pressure(PaCO2).Results: Serum NT-proBNP level was significantly(P〈0.05),experimental group was significantly higher than the control group.Varying degrees of hypoxemia compared NT-proBNP level was significantly(P 〈0.05),prompts: NT-proBNPs levels increased with the decrease of PaO2.Experimental group of 68 patients with COPD PaO2and serum NT-proBNP level was negatively correlated(a 0.641,P 〈0.05),while PaC02 serum NT-proBNP levels with no correlation(r = 0.143,P〉 0.05).Conclusion: Plasma NTproBNP level of detection of respiratory failure in COPD diagnosis,severity and prediction of development and change have better clinical value in guiding treatment of COPD patients with respiratory failure are important and warrant further study.
出处 《中国医药导刊》 2012年第5期758-759,共2页 Chinese Journal of Medicinal Guide
关键词 脑利钠肽N端前体肽 阻塞性肺疾病 慢性病 呼吸衰竭 N-terminal brain natriuretic peptide precursor peptide; Obstructive pulmonary disease; Chronic disease; respiratory failure
  • 相关文献

参考文献11

二级参考文献35

  • 1史晓敏,徐国宾,夏铁安.N末端B型钠尿肽原对充血性心力衰竭患者预后及危险分层评价的价值[J].中华检验医学杂志,2006,29(1):27-30. 被引量:56
  • 2刘希增,杨洪兰,刘华恩.脑型钠利尿肽对充血性心力衰竭疗效评价的临床意义[J].山东医药,2007,47(10):13-13. 被引量:6
  • 3陈灏珠.实用内科学(11版)[M].北京:人民卫生出版社,2001.1866~1867.
  • 4de Denus S, Pharand C, Willamson DR. Brain natriuretic peptide in the management of heart failure: the versatile neurohormone. Chest ,2004,125:652-668.
  • 5Cataliotti A, Boerrigter G, Costello-Boerriqter LC, et al. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure. Circulation, 2004,109 : 1680-1685.
  • 6Anan F, Takahashi N, Ooie T, et al. Role of insulin resistance in nondipper essential hypertension patients. Hypertens Res, 2003, 26 : 669 -676.
  • 7Cargill RI, Lipworth BJ. Atrial natriuretie peptide and brain natriuretie peptide in eor pulnonale, hemodynamie and endocrine effects. Chest, 1996, 110:1220-1225.
  • 8Klinger JR, Warburton RR, .Pietras L, et al. Brain natriutic peptide inhibits hypoxic pulmonary hypertention in rats J Appl Physiol, 1998,84 : 1646-1652.
  • 9Hanno H, Leuchte, Rainer A,et al. Brain natriuretic peptide is a prognostic parameter in chronic lung disease. Am J Respir Crit Care Med, 2006,173 : 744-750.
  • 10Morrison LK, Harrison A, Krishnaswamy P, et al. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol,2002 ,39 :202-209.

共引文献5655

同被引文献41

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部